glp-1/gip agonists Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Targeting GLP-1, GIP & GCG
Description
5 Discussion GLP-1RAs have emerged as a paradigm-shifting class of agents, with therapeutic benefits that extend well beyond glycemic control in type 2 diabetes
Shang Q, Saumoy M, Holst JJ, Salen G, Xu G
Our secondary outcomes were suicidal ideation, hospital admission for self-harm, and suicide, each considered separately
E., Battaglia F., Hen R
Exposure was defined through prescriptions rather than confirmed adherence
Statements, recommendations, and opinions expressed in the webinar and this summary article are those of individual presenters and participants
